Category: Growing
-
![Heritage Cannabis’ (CANN.C) subsidiary Endocanna Health licenses DNA kits for Empower Clinics (CBDT.C)]()
Heritage Cannabis’ (CANN.C) subsidiary Endocanna Health licenses DNA kits for Empower Clinics (CBDT.C)
Endocanna Health, a subsidiary of Heritage Cannabis (CANN.C), has agreed to manufacture and license its patent-pending Endocannabinoid DNA Test Kits to Empower Clinics (CBDT.C). Imagine a product tuned in directly to your specific DNA to give you exactly what you need when you need it. That’s what Endocanna’s test kits offer. Endocanna’s kits provide personalized…
-
Aurora (ACB.T) predicts Q4 $100 million revenue – then the calculator jams
On Aug. 6, 2019 Aurora Cannabis (ACB.T) released “selected financial metrics” for Q4 2019 – which ended June 30, 2019. This gives investors a sneak peek, prior to official audited earnings, at some of the numbers. ACB’s Q4, 2019 Financial Projections: Last quarter Aurora reported $65.1 million net revenue, so the Q4 number is up…
-
Wayland Group (WAYL.C) crumbles, to RTO with illiquid crypto company, CEO Ben Ward dumped
Canadian licensed cannabis producer The Wayland Group (WAYL.C), formerly Maricann, currently halted for not being able to get their financials through three different audit teams, has succumbed. Long halted at $0.74 in Canada, though still trading on the US OTC at C$0.26, Wayland announced late Friday night, when most people were either asleep or into…
-
Aphria (APHA.T) stuns cannabis sector, runs a quarterly profit – up 35%
Just 48 hrs after I posted my ‘can we get some freaking adults into this weed space‘ screed, Aphria (APHA.T) has responded with a quarterly profit. An actual quarterly profit. Let’s be clear: I had nothing to do with that, other than maybe sensing a sector change in thinking that the Aphria folks have embraced,…
-
GTEC Holdings (GTEC.C) subsidiary gets a sales license, makes product available nationwide
It’s like clockwork, every damn Friday afternoon. I think I’m getting out early to enjoy the weekend, anticipating the chance to get shittered on negronis, only for Health Canada to drop one of their usual Friday afternoon updates on their list of cannabis licenses. And, as per usual, it’s GTEC Holdings (GTEC.C) that’s getting another…
-
![Hemptown Organics opens financing to non-accredited investors]()
Hemptown Organics opens financing to non-accredited investors
A few years ago, we wrote one of our defining pieces at Equity.Guru, an article that opened a new world up for a variety of investors, and introduced them to a pre-public listing deal that, for a change, was opening up to the little guy. So you missed Canopy/Tweed coming to the market. You stood…
-
GONE: CannTrust (TRST.V) execs bounced by board after 3 Stooges-like revelations of stupidity
We may never know whether it was the brazen hubris of doing a promotional video in front of an unlicensed grow room filled with illegal plants, or if it was the email trail the Globe and Mail discovered yesterday that showed top brass at CannTrust (TRST.V) were not only aware the company was growing illegal…
-
CannTrust (TRST.T) executives should go to jail: Emails show deliberate criminality
There’s a difference between incompetence and criminality. Incompetence is “What? That’s weed? I thought those were tomato seeds!” Criminality is “1) RG8 is not licenced but has plants in it; 2) RG9 is not licenced but we are intending to put plants in it on Monday; 3) PA2A-E are not licenced but we have moved…
-
‘The Plant’ by Westleaf (WL.V) gets first cannabis derivatives contract, and it’s huge
Three weeks after we introduced The Plant by Westleaf (WL.V), the state-of-the-art production facility located in Calgary, the company secured its first major contract to supply cannabis derivatives products. Under the contract, Westleafw will supply approximately CAD$4 million worth of the good stuff to Delta 9 (NINE.V), a vertically-integrated cannabis company located in Winnipeg, Manitoba. Delta…
-
Flowr (FLWR.V) tries again after canceled high priced financing kills stock, walks into same pole
We’re seeing a lot of cannabis companies inflicting friendly fire on themselves these past few months, as companies dependent on big financings find the market isn’t as enamored with growth at all costs as they are. We’ve seen big write downs based on assets purchased with debentures that later convert to shares at unhelpful prices,…
